Quantcast

Latest Élan Stories

2009-09-17 08:00:00

NEW BRUNSWICK, N.J. and DUBLIN, Sept. 17 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) and Elan Corporation plc (NYSE: ELN) today announced that JANSSEN Alzheimer Immunotherapy, a newly formed subsidiary of Johnson & Johnson, has completed the acquisition of substantially all of the assets and rights of Elan related to its Alzheimer's Immunotherapy Program (AIP). In addition, Johnson & Johnson, through its affiliate, Janssen Pharmaceutical, has invested $885 million in...

2009-09-12 16:46:10

Results further support the benefits of TYSABRI for multiple sclerosis patients Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI® (natalizumab) experienced an improvement in both their physical function and psychological well-being. Findings from the study, which was performed in...

2009-08-06 09:10:00

Promise of revolutionary orally-administered drugs to combat Alzheimer's began journey 8 years ago "Finding a needle in a haystack - 4 molecules out of a million" NEW YORK, Aug. 6 /PRNewswire-USNewswire/ -- New therapeutics funded by the Alzheimer's Drug Discovery Foundation (ADDF), have achieved a significant milestone in their development as they advance toward the clinic, the ADDF announced today. PharmatrophiX, a biotechnology company founded in 2005 with funding from ADDF, has...

2009-07-28 11:40:00

NEW YORK, July 28 /PRNewswire/ -- elan: The Guide to Global Muslim Culture is excited to announce the launch of its new website (http://www.elanthemag.com), which offers witty, engaging and thought-provoking takes on all of today's lifestyle topics pertaining to the contemporary Muslim culture. From news and politics, to fashion and art, the new elan site -- centered on its interactive blog -- provides a provocative look at the modern Islamic world, for Muslims and non-Muslims alike....

2009-07-14 08:00:00

VIENNA, Austria, July 14 /PRNewswire-FirstCall/ -- Elan Corporation, plc (NYSE: ELN) and Wyeth (NYSE: WYE) presented information this week at the Alzheimer Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) from seven posters and one podium presentation about the growing burden of care and costs associated with Alzheimer's disease (AD) and how to measure them. This information sheds light on the impact of AD, which, as the population ages, will place a significant...

2009-07-02 06:57:00

NEW BRUNSWICK, N.J. and DUBLIN, July 2 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) and Elan Corporation plc (NYSE: ELN) today announced a definitive agreement whereby Johnson & Johnson will acquire substantially all of the assets and rights of Elan related to its Alzheimer's Immunotherapy Program (AIP Program), through a newly formed company. In addition, Johnson & Johnson, through its affiliate, will invest $1 billion in Elan in exchange for newly issued American...

2009-05-04 09:33:00

DUBLIN, May 4 /PRNewswire/ -- Circ Pharma Limited ("Circ Pharma") and Elan Corporation plc ("Elan") today announced that they have entered into a Development Agreement to develop a chronotherapeutic formulation of Tramadol for the treatment of moderate to moderately severe pain. The product incorporates Circ Pharma's proprietary drug delivery technology enabling once daily dosing. Circ's technology provides for minimized delivery to the body during sleeping hours, acceleration of...

2009-04-08 14:57:00

A Taiwanese technology firm filed suit against Apple Computer claiming Apple violated two touch-screen patents, the company said. We couldn't find a common viewpoint with Apple, so we decided we had to take action, Elan Microelectronics spokesman Dennis Liu told The New York Times. The companies had been discussing licensing agreements for two years, Liu said. The suit claims Apple's MacBook computer, iPhone and iPod touch violate Elan's patent rights for its multi-touch technology, the...

2009-01-08 11:56:00

elan Explores the Hopes and Aspirations for America's Next Leader NEW YORK, Jan. 8 /PRNewswire/ -- elan: The Guide To Global Muslim Culture announced today the publication of its special edition to coincide with the inauguration of Barack Obama as the 44th President of the United States of America. elan's cover story, Muslim World Embraces Obama, explores the hopes and aspirations of Muslims regarding America's new President. (Photo:...

2009-01-08 07:00:00

SAN DIEGO, Jan. 8 /PRNewswire/ -- Victory Pharma, Inc., a privately held specialty pharmaceutical company, today announced that it is launching two additional dosage strengths of Naprelan(R) (naproxen sodium) Controlled-Release Tablets. NAPRELAN is a once-daily, controlled-release formulation of naproxen sodium, a non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of a number of conditions, including osteoarthritis, rheumatoid arthritis and management of mild to...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related